Clinical-Scale Production of CAR-T Cells for the Treatment of Melanoma Patients by mRNA Transfection of a CSPG4-Specific CAR under Full GMP Compliance

Chimeric antigen receptor (CAR)-T cells already showed impressive clinical regressions in leukemia and lymphoma. However, the development of CAR-T cells against solid tumors lags behind. Here we present the clinical-scale production of CAR-T cells for the treatment of melanoma under full GMP complia...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiesinger, Manuel, März, Johannes, Kummer, Mirko, Schuler, Gerold, Dörrie, Jan, Schuler-Thurner, Beatrice, Schaft, Niels
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Technical Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721485/
https://www.ncbi.nlm.nih.gov/pubmed/31426437
http://dx.doi.org/10.3390/cancers11081198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721485/
https://www.ncbi.nlm.nih.gov/pubmed/31426437
http://dx.doi.org/10.3390/cancers11081198

Ejemplares similares